These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35101284)

  • 1. Transoral robotic surgery for oropharyngeal cancer in the era of chemoradiation therapy.
    Meccariello G; Cammaroto G; Iannella G; De Vito A; Ciorba A; Bianchini C; Corazzi V; Pelucchi S; Vicini C; Capaccio P
    Auris Nasus Larynx; 2022 Aug; 49(4):535-546. PubMed ID: 35101284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
    Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma - A systematic review of the literature.
    Yeh DH; Tam S; Fung K; MacNeil SD; Yoo J; Winquist E; Palma DA; Nichols AC
    Eur J Surg Oncol; 2015 Dec; 41(12):1603-14. PubMed ID: 26461255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.
    Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
    Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
    Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transoral robotic surgery and intensity-modulated radiotherapy in the treatment of the oropharyngeal carcinoma: a systematic review and meta-analysis.
    De Virgilio A; Costantino A; Mercante G; Pellini R; Ferreli F; Malvezzi L; Colombo G; Cugini G; Petruzzi G; Spriano G
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1321-1335. PubMed ID: 32696250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
    Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
    Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Options for Locally Advanced Oropharyngeal Cancer.
    Qureshi HA; Abouyared M; Barber B; Houlton JJ
    Curr Treat Options Oncol; 2019 Apr; 20(5):36. PubMed ID: 30931485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U
    Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
    Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
    Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upfront transoral robotic surgery (TORS)
    Zorzi SF; Agostini G; Chu F; Tagliabue M; Pietrobon G; Corrao G; Volpe S; Marvaso G; Colombo F; Cossu Rocca M; Gandini S; Gaeta A; Ruju F; Alterio D; Ansarin M
    Acta Otorhinolaryngol Ital; 2022 Aug; 42(4):334-347. PubMed ID: 35938555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
    Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
    Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
    Smith RV; Schiff BA; Garg M; Haigentz M
    Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of transoral robotic surgery in the management of oropharyngeal squamous cell carcinoma: a current review.
    Sansoni ER; Gross ND
    Curr Oncol Rep; 2015 Mar; 17(3):432. PubMed ID: 25687805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feeding Tube Placement Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.
    Feng AL; Holcomb AJ; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Holman A; Kammer RE; Goldsmith TA; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
    Otolaryngol Head Neck Surg; 2022 Apr; 166(4):696-703. PubMed ID: 34154449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-utility of two minimally-invasive surgical techniques for operable oropharyngeal cancer: transoral robotic surgery versus transoral laser microsurgery.
    Parimbelli E; Soldati F; Duchoud L; Armas GL; de Almeida J; Broglie M; Quaglini S; Simon C
    BMC Health Serv Res; 2021 Oct; 21(1):1173. PubMed ID: 34711226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.